Search research articles
Contact Us
Filters
Showing results (31-40 of 64) with videos related to
Page
of 7
Sort By:
The Prostate
|
December 12, 2023
Targeting glutamine dependence with DRP-104 inhibits proliferation and tumor growth of castration-resistant prostate cancer
David Moon, J Spencer Hauck, Xue Jiang, et al.
Journal of Clinical Lipidology
|
June 1, 2024
Dyslipidemia management in women of reproductive potential: An Expert Clinical Consensus from the National Lipid Association
Anandita Agarwala, Dave L Dixon, Eugenia Gianos, et al.
Molecular Cancer Therapeutics
|
October 7, 2010
Compensatory insulin receptor (IR) activation on inhibition of insulin-like growth factor-1 receptor (IGF-1R): rationale for cotargeting IGF-1R and IR in cancer
Elizabeth Buck, Prafulla C Gokhale, Susan Koujak, et al.
Cancer Chemotherapy and Pharmacology
|
February 28, 2008
Identification and validation of phospho-SRC, a novel and potential pharmacodynamic biomarker for dasatinib (SPRYCEL), a multi-targeted kinase inhibitor
Feng Roger Luo, Yu Chen Barrett, Zheng Yang, et al.
NPJ Precision Oncology
|
November 11, 2024
Benchmark of screening markers for KEAP1/NFE2L2 mutations and joint analysis with the K1N2-score
Christoph Arolt, Andreas H Scheel, Margaret Dugan, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer
|
July 20, 2023
KEAP1/NFE2L2 Pathway Signature Outperforms KEAP1/NFE2L2 Mutation Status and Reveals Alternative Pathway-Activating Mutations in NSCLC
Christoph Arolt, Margaret Dugan, Robert Wild, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
August 3, 2005
Prediction of active drug plasma concentrations achieved in cancer patients by pharmacodynamic biomarkers identified from the geo human colon carcinoma xenograft model
Feng R Luo, Zheng Yang, Huijin Dong, et al.
Journal of Natural Products
|
June 28, 2003
Cytotoxic flavone analogues of vitexicarpin, a constituent of the leaves of Vitex negundo
Fredyc Díaz, Daniel Chávez, Dongho Lee, et al.
Cancer Letters
|
July 4, 2024
A genome-wide CRISPR screen reveals that antagonism of glutamine metabolism sensitizes head and neck squamous cell carcinoma to ferroptotic cell death
Michael M Allevato, Sally Trinh, Keiichi Koshizuka, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association
|
July 13, 2023
Associations of dietary cholesterol and fat, blood lipids, and risk for dementia in older women vary by APOE genotype
Michelle M Dunk, Jie Li, Simin Liu, et al.
Page
of 7
Search research articles
Search
Showing results (31-40 of 64) with videos related to
Sort By:
Page
of 7
The Prostate
|
December 12, 2023
Targeting glutamine dependence with DRP-104 inhibits proliferation and tumor growth of castration-resistant prostate cancer
David Moon, J Spencer Hauck, Xue Jiang, et al.
Journal of Clinical Lipidology
|
June 1, 2024
Dyslipidemia management in women of reproductive potential: An Expert Clinical Consensus from the National Lipid Association
Anandita Agarwala, Dave L Dixon, Eugenia Gianos, et al.
Molecular Cancer Therapeutics
|
October 7, 2010
Compensatory insulin receptor (IR) activation on inhibition of insulin-like growth factor-1 receptor (IGF-1R): rationale for cotargeting IGF-1R and IR in cancer
Elizabeth Buck, Prafulla C Gokhale, Susan Koujak, et al.
Cancer Chemotherapy and Pharmacology
|
February 28, 2008
Identification and validation of phospho-SRC, a novel and potential pharmacodynamic biomarker for dasatinib (SPRYCEL), a multi-targeted kinase inhibitor
Feng Roger Luo, Yu Chen Barrett, Zheng Yang, et al.
NPJ Precision Oncology
|
November 11, 2024
Benchmark of screening markers for KEAP1/NFE2L2 mutations and joint analysis with the K1N2-score
Christoph Arolt, Andreas H Scheel, Margaret Dugan, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer
|
July 20, 2023
KEAP1/NFE2L2 Pathway Signature Outperforms KEAP1/NFE2L2 Mutation Status and Reveals Alternative Pathway-Activating Mutations in NSCLC
Christoph Arolt, Margaret Dugan, Robert Wild, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
August 3, 2005
Prediction of active drug plasma concentrations achieved in cancer patients by pharmacodynamic biomarkers identified from the geo human colon carcinoma xenograft model
Feng R Luo, Zheng Yang, Huijin Dong, et al.
Journal of Natural Products
|
June 28, 2003
Cytotoxic flavone analogues of vitexicarpin, a constituent of the leaves of Vitex negundo
Fredyc Díaz, Daniel Chávez, Dongho Lee, et al.
Cancer Letters
|
July 4, 2024
A genome-wide CRISPR screen reveals that antagonism of glutamine metabolism sensitizes head and neck squamous cell carcinoma to ferroptotic cell death
Michael M Allevato, Sally Trinh, Keiichi Koshizuka, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association
|
July 13, 2023
Associations of dietary cholesterol and fat, blood lipids, and risk for dementia in older women vary by APOE genotype
Michelle M Dunk, Jie Li, Simin Liu, et al.
Page
of 7